No abstract

Objective: Nutritional intake is one of the most common environmental risk factors for polycystic ovary syndrome (PCOS) because it is associated with obesity and insulin resistance. The aim of this study was to determine the relationship between micronutrient intake and androgen levels associated with PCOS. Material and Methods: This cross-sectional study was performed in patients with PCOS divided into two groups, normoandrogenic (NA) and hyperandrogenic (HA), and healthy controls. Dietary intake assessment was performed using a modified 38-item semi-quantitative food frequency questionnaire. Bivariate, correlation, and multivariate analyses were performed to determine the association between study variables. Results: There were 79 patients with PCOS, of whom 50 were NA and 29 were HA. There were 66 subjects in the healthy control group. The baseline characteristics in all groups were similar, except for body mass index and hormonal profile which were elevated in the HA group compared to the other groups. There was a significant negative correlation between the free androgen index (FAI) and intake of vitamin B 1 , vitamin B 2 , niacin, vitamin B 6 , calcium, and iron in the NA group, while this association was absent in the HA group. Multivariate linear regression analysis showed that the intake of vitamin B 6 , vitamin C, niacin, and iron had a significant effect on the FAI. Conclusion: There is an effect of micronutrient intake on androgen levels in women with PCOS. The association was more significant in NA PCOS than in the HA PCOS groups. These findings suggest an association between micronutrients, androgens and PCOS at a systemic level.

Background Recently, coronary artery bypass graft (CABG) techniques, both on-pump (ONCABG) and off-pump (OPCABG), were compared to seek the most effective approach to reduce the cost of prolonged intensive care unit length of stay (ICU LOS) and mortality. This study aims to compare ICU LOS and mortality in ONCABG and OPCABG. Results Demographic data of 1569 patients show the variance of characteristics. The analysis shows significant and longer ICU LOS in OPCABG than ONCABG (2.151 ± 0.100 vs. 1.573 ± 0.246 days; p = 0.028). Similar results were demonstrated after adjustment of covariates effects (3.146 ± 0.281 vs. 2.548 ± 0.245 days; p = 0,022). Logistic regression shows no significant difference in mortality in OPCABG and ONCABG, both in the unadjusted (OR [CI 95%] 1.133 [0.485–2.800]; p = 0.733) and the adjusted models (OR [CI 95%] 1.133 [0.482–2.817]; p = 0,735). Conclusion ICU LOS was significantly longer in OPCABG patients than in ONCABG patients in the author's centre. There was no significant difference in mortality between the two groups. This finding highlights a discrepancy between recently published theories and the practices observed in the author's centre.

Background Coronary artery bypass graft (CABG) techniques, both on-pump (ONCABG) and off-pump (OPCABG), were compared recently in order to seek the most effective technique to reduce the cost of prolonged intensive care unit length of stay (ICU LOS) and mortality. This study aim to compare ICU LOS and mortality in ONCABG and OPCABG Methods Secondary data was used in this study. Statistical analyses were performed in SAS 9.4 (SAS Institute Inc, Cary, NC). The analyses included descriptive statistics for all variables, generalized linear models for ICU LOS, and logistic regression for mortality. All models were fitted in bivariate and multivariate forms to consider multiple factors (i.e., age, sex, race, EF, comorbidities such as hypertension, diabetes, and obesity). Statistical significance was determined at the level of alpha = 0.05. Results Demographic data of 1569 patients shows variance of characteristics. The analysis shows significant and longer ICU LOS in OPCABG (Mean = 0.558; SE = 0.026 vs Mean = 0.408; SE = 0.633; p < 0.001). Similar results were demonstrated after adjustment of covariates effects (OPCABG Mean = 0.816; SE = 0.073 vs ONCABG Mean = 0.661; SE = 0.091). Logistic regression shows that there was no significant difference of mortality in OPCABG and ONCABG, both in the unadjusted (OR = 1.165, 95%, CI = 0.485-2.8) and the adjusted model (OR = 1.165, 95% CI = 0.482–2.817). Conclusion ICU LOS was significantly longer in OPCABG patients than in ONCABG patients. There was no significant difference in mortality between the two groups.